Emily Weg, MD
Locations of Practice
Seattle Cancer Care Alliance (SCCA) – South Lake Union
1354 Aloha Street
Seattle, WA 98109
University of Washington Medical Center Montlake – Radiation Oncology Center
1959 NE Pacific Street
Seattle, WA 98195
SCCA Proton Therapy Center
1570 N 115th Street
Seattle, WA 98133
Dr. Weg specializes in treating genitourinary cancers. She treats patients at the Seattle Cancer Care Alliance, University of Washington Medical Center at Montlake, and SCCA Proton Therapy Center. She has expertise in image guided radiation therapy, stereotactic body radiation therapy, proton therapy, and brachytherapy.
Patient Care Philosophy
I strive to treat each patient as I would treat my own family member: with compassion, careful deliberation, and excellent clinical care.
Education and Training
College: Columbia University
Medical Education: Icahn School of Medicine at Mount Sinai
Residency: Radiation Oncology, Memorial Sloan Kettering Cancer Center
Weg ES, Pei X, Kollmeier MA, McBride SM, Zelefsky MJ. Dose-escalated intensity modulated radiation therapy for prostate cancer: 15-year outcomes data. Adv Radiat Oncol 2019 Apr 4;4(3):492-499. doi: 10.1016/j.adro.2019.03.012.
Weg ES, Kollmeier MA, McBride SM, Novak C, Pei X, Zelefsky MJ. Cigarette smoking during external beam radiation therapy for prostate cancer is associated with an increased risk of prostate cancer-specific mortality and treatment-related toxicity. BJU Int 2015 Oct;116(4):596-603. doi: 10.1111/bju.12969.
Stopsack KH, Nandakumar S, Wibmer AG, Haywood S, Weg ES, Barnett ES, Kim CJ, Carbone EA, Vasselman SE, Nguyen B, Hullings MA, Scher HI, Morris MJ, Solit DB, Schultz N, Kantoff PW, Abida W. Oncogenic Genomic Alterations, Clinical Phenotypes, and Outcomes in Metastatic Castration-Sensitive Prostate Cancer. Clin Cancer Res. 2020 Jul 1;26(13):3230-3238. doi: 10.1158/1078-0432.CCR-20-0168.
Nguyen B, Mota JM, Nandakumar S, Stopsack KH, Weg E, Rathkopf D, Morris MJ, Scher HI, Kantoff PW, Gopalan A, Zamarin D, Solit DB, Schultz N, Abida W. Pan-cancer Analysis of CDK12 Alterations Identifies a Subset of Prostate Cancers with Distinct Genomic and Clinical Characteristics. Eur Urol. 2020 Apr 19:S0302-2838(20)30199-8. doi: 10.1016/j.eururo.2020.03.024.
Kohutek ZA, Weg ES, Pei X, Shi W, Zhang Z, Kollmeier MA, Zelefsky MJ. Long-term Impact of Androgen-deprivation Therapy on Cardiovascular Morbidity After Radiotherapy for Clinically Localized Prostate Cancer. Urology. 2016 Jan;87:146-52. doi: 10.1016/j.urology.2015.08.029.